Complementation of human papillomavirus type 16 E6 and E7 by Jagged1-specific Notch1-phosphatidylinositol 3-kinase signaling involves pleiotropic oncogenic functions independent of CBF1;Su(H);Lag-1 activation

Journal of Virology

Volumn 79, Issue 12, 2005, Pages 7889-7898

  Veeraraghavalu, Karthikeyan ^a   Subbaiah, Vanitha K ^a   Srivastava, Sweta ^a   Chakrabarti, Oishee ^a   Syal, Ruchi ^a   Krishna, Sudhir ^a  

^a TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

JAGGED1; NOTCH1 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN CBF1; PROTEIN DELTA1; PROTEIN DELTEX1; PROTEIN E6; PROTEIN E7; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VIRUS ONCOGENE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CALCIUM-BINDING PROTEINS; CARCINOMA, SQUAMOUS CELL; CELL LINE; CELL LINE, TUMOR; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHEMOKINES, CC; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGE INFLAMMATORY PROTEIN-1; MEMBRANE PROTEINS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; RECEPTOR, NOTCH1; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOKINE; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 19944365553     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.12.7889-7898.2005     Document Type: Article

References (47)

1. Amsen, D., N. J. M. Blander, G. R. Lee, K. Tanigaki, T. Honjo, and R. A. Flavell. 2004. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117:515-526.
2. Artavanis-Tsakonas, S., M. D. Rand, and R. J. Lake. 1999. Notch signalling: cell fate control and signal integration in development. Science 284:770-776.
3. Ascano, J. M., L. J. Beverly, and A. J. Capobianco. 2003. The C-terminal PDZ ligand of JAGGED1 is essential for cellular transformation. J. Biol. Chem. 278:8771-8779.
4. Aster, J. C., L. Xu, F. G. Karnell, V. Patriub, J. C. Pui, and W. S. Pear. 2000. Essential roles for ankyrin repeat and transctivation domains in induction of T-cell leukemia by notch1. Mol. Cell. Biol. 20:7505-7515.
5. Bakin, A. V., A. K. Tomlinson, N. A. Bhowmick, H. L. Moses, and C. L. Arteaga. 2000. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275:36803-36810.
6. Blaumueller, C. M., H. Qi, P. Zagouras, and S. Artavanis-Tsakonas. 1997. Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane. Cell 90:281-291.
7. Cairns, R. A., and R. P. Hill. 2004. A fluorescent orthotopic model of metastatic cervical carcinoma. Clin. Exp. Metastasis 21:275-281.
8. Chakrabarti, O., K. Veeraraghavalu, V. Tergaonkar, Y. Liu, E. Androphy, M. A. Stanley, and S. Krishna. 2004. Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by Notch signaling and oncogenic Ras. J. Virol. 78:5934-5945.
9. Daniel, B., A. Rangarajan, G. Mukherjee, E. Vallikad, and S. Krishna. 1997. The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J. Gen. Virol. 78:1095-1101.
10. Doerfler, P., M. S. Shearman, and R. M. Perlmutter. 2001. Presenilin-dependent gamma-secretase activity modulates thymocyte development. Proc. Natl. Acad. Sci. USA. 98:9312-9317.
11. Dumont, E., K. P. Fuchs, G. Bommer, B. Christoph, E. Kremmer, and B. Kempkes. 2000. Neoplastic transformation by Notch is independent of transcriptional activation by RBP-J. signalling. Oncogene 19:556-556.
12. Gray, G. E., R. S. Mann, E. Mitsiadis, D. Henrique, M. L. Carcangiu, A. Banks, J. Leiman, D. Ward, D. Ish-Horowitz, and S. Artavanis-Tsakonas. 1999. Human ligands of the Notch receptor. Am. J. Pathol. 154:785-794.
13. Grego-Bessa, J., J. Diez, L. A. Timmerman, and J. L. de la Pompa. 2004. Notch and epithelial-mesenchyme transition in development and tumor progression: another turn of the screw. Cell Cycle 3:718-721.
14. Herwig, R., P. Aanstad, M. Clark, and H. Lehrach. 2001. Statistical evaluation of differential expression on cDNA nylon arrays with replicated experiments. Nucleic Acids Res. 29:E117.
15. Hicks, C., S. H. Johnston, G. diSibio, A. Collazo, T. F. Vogt, and G. Weinmaster. 2000. Fringe differentially modulates Jagged1 and Delta1 signalling through Notch1 and Notch2 receptors in mammalian cells. Nat. Cell Biol. 2: 515-520.
16. Jaleco, A. C., H. Neves, E. Hooyberg, P. Gameiro, N. Clode, M. Haury, D. Henrique, and L. Parreira. 2001. Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation. J. Exp. Med. 194: 991-1001.
17. Jeffries, S., and A. J. Capobianco. 2000. Neoplastic transformation by Notch requires nuclear localization. Mol. Cell. Biol. 20:3928-3941.
18. Jonsson, F., and E. Knust. 1996. Distinct functions of the Drosophila genes Serrate and Delta revealed by ectopic expression during wing development. Dev. Genes Evol. 206:91-101.
19. Karavanova, I., S. Vainio, and I. Thesleff. 1992. Transient and recurrent expression of the Egr-1 gene in epithelial and mesenchymal cells during tooth morphogenesis suggest involvement in tissue interactions and in determination of cell fate. Mech. Dev. 39:41-50.
20. Kishi, N., Z. Tang, Y. Maeda, A. Hirai, R. Mo, M. Ito, S. Suzuki, K. Nakao, T. Kinoshita, T. Kadesch, C. Hui, S. Artavanis-Tsakonas, H. Okano, and K. Matsuno. 2001. Murine homologs of deltex define a novel gene family involved in vertebrate Notch signaling and neurogenesis. Int. J. Dev. Neurosci. 19:21-35.
21. Lampugnani, M. G. 1999. Cell migration into a wounded area in vitro. Methods Mol. Biol. 96:177-182.
22. Lathion, S., J. Schaper, P. Beard, and K. Raj. 2003. Notch1 can contribute to viral-induced transformation of primary human keratinocytes. Cancer Res. 63:8687-8694.
23. Lowell, S., P. Jones, I. Le Roux, J. Dunne, and F. M. Watt. 2000. Stimulation of human epidermal differentiation by delta-notch signalling at the boundaries of stem cell clusters. Curr. Biol. 10:491-500.
24. Martinez Arias, A., V. Zecchini, and K. Brennan. 2002. CSL-independent Notch signaling: a checkpoint in cell fate decisions during development? Curr. Opin. Genet. Dev. 12:524-533.
25. Masuya, M., N. Katayama, N. Hoshino, H. Nishikawa, S. Sakano, H. Araki, H. Mitani, H. Suzuki, H. Miyashita, K. Kobayashi, K. Nishii, N. Minami, and H. Shiku. 2002. The soluble Notch ligand, Jagged-1, inhibits proliferation of CD34+ macrophage progenitors. Int. J. Hematol. 75:269-276.
26. Matsubayashi, Y., M. Ebisuya, S. Honjoh, and E. Nishida. 2004. ERK activation propagates in epithelial cell sheets and regulates their migration during wound healing. Curr. Biol. 14:731-735.
27. Matsuno, K., D. Eastman, T. Mitsiades, A. M. Quinn, M. L. Carcanciu, P. Ordentlich, T. Kadesch, and S. Artavanis-Tsakonas. 1998. Hum. deltex is a conserved regulator of Notch signalling. Nat. Genet. 19:74-78.
28. Matsuno, K., M. Ito, K. Hori, F. Miyashita, S. Suzuki, N. Kishi, S. Artavanis-Tsakonas, and H. Okano. 2002. Involvement of a proline-rich motif and RING-H2 finger of Deltex in the regulation of Notch signaling. Development 129:1049-1059.
29. Nair, P., K. Somasundaram, and S. Krishna. 2003. Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a phosphatidylinositol 3-kinase-protein kinase B/Akt-dependent pathway. J. Virol. 77:7106-7112.
30. Nickoloff, B. J., J. Z. Qin, V. Chaturvedi, M. F. Denning, B. Bonish, and L. Miele. 2002. Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPAR-gamma. Cell Death Differ. 9:842-855.
31. Ordentlich, P., A. Lin, C. P. Shen, C. Blaumueller, K. Matsuno, S. Artavanis-Tsakonas, and T. Kadesch. 1998. Notch inhibition of E47 supports the existence of a novel-signaling pathway. Mol. Cell. Biol. 18:2230-2239.
32. Perez, O. D., S. Kinoshita, Y. Hitoshi, D. G. Payan, T. Kitamura, G. P. Nolan, and J. B. Lorens. 2002. Activation of the PKB/AKT pathway by ICAM-2. Immunity 16:51-65.
33. Rangarajan, A., R. Syal, S. Selvarajah, O. Chakrabarti, A. Sarin, and S. Krishna. 2001. Activated Notch1 signaling cooperates with papillomavirus oncogenes in transformation and generates resistance to apoptosis on matrix withdrawal through PKB/Akt. Virology 286:23-30.
34. Ronchini, C., and A. J. Capobianco. 2001. Induction of cyclin D1 transcription and CDK2 activity by Notch (ic): implication for cell cycle disruption in transformation by Notch (ic). Mol. Cell. Biol. 17:5925-5934.
35. Sade, H., S. Krishna, and A. Sarin. 2004. The anti-apoptotic effect of Notch-1 requires p561ck-dependent, Akt/PKB-mediated signaling in T cells. J. Biol. Chem. 279:2937-2944.
36. Skobe, M., P. Rockwell, N. Goldstein, S. Vosseler, and N. E. Fusenig. 1997. Halting angiogenesis suppresses carcinoma cell invasion. Nat. Med. 3:1222-1227.
37. Talora, C., D. C. Sgroi, C. P. Crum, and G. P. Dotto. 2002. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. Genes Dev. 16:2252-2263.
38. Thelu, J., P. Rossio, and B. Favier. 2002. Notch signalling is linked to epidermal cell differentiation level in basal cell carcinoma, psoriasis and wound healing. BMC Dermatol. 2:7-17.
39. Thiery, J. P. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2:442-454.
40. Timmerman, L. A., J. Grego-Bessa, A. Raya, E. Bertran, J. M. Perez-Pomares, J. Diez, S. Aranda, S. Palomo, F. McCormick, J. C. Izpisua-Belmonte, and J. L. de la Pompa. 2004. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 18:99-115.
41. Veeraraghavalu, K., M. Pett, V. K. Rekha, P. Nair, A. Rangarajan, M. A. Stanley, and S. Krishna. 2004. Papillomavirus-mediated neoplastic progression is associated with reciprocal changes in Jagged 1 and Manic Fringe expression linked to Notch activation. J. Virol. 78:8687-8700.
42. Yamamoto, N., S. Yamamoto, F. Inagaki, M. Kawaichi, A. Fukamizu, N. Kishi, K. Matsuno, K. Nakamura, G. Weinmaster, H. Okano, and M. Nakafuku. 2001. Role of Deltex-1 as a transcriptional regulator downstream of the Notch receptor. J. Biol. Chem. 276:45031-45040.
43. Yi, J. Y., K. C. Hur, E. Lee, Y. J. Jin, C. L. Arteaga, and Y. S. Son. 2002. TGFbeta1-mediated epithelial to mesenchymal transition is accompanied by invasion in the SiHa cell line. Eur. J. Cell Biol. 81:457-468.
44. Zagouras, P., S. Stifani, C. M. Blaumueller, M. L. Carcangiu, and S. Artavanis-Tsakonas. 1995. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc. Natl. Acad. Sci. USA 92:6414-6418.
45. Zavadil, J., L. Cermak, N. Soto-Nieves, and E. P. Bottinger. 2004. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 23:1155-1165.
46. Zehbe, I., E. Wilander, H. Delius, and M. Tommasino. 1998. Hum. papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 58:829-833.
47. zur Hausen, H. 2002. Papillomaviruses and cancer: From basic studies to clinical applications. Nat. Rev. Cancer 2:342-350.